Meta-analysis study done in the recent past indicated the use of cerebrospinal fluid (CSF) t-tau along with p-tau and Aβ42 in the early detection of AD in patients with mid-cognitive impairment(MCI) with a sensitivity of 95% [67]. This evidence concerns the gene MAPT and Alzheimer disease.